Lexaria Bioscience (CSE:LXX,OTCQB:LXRP) President John Docherty was recently featured in a BTV segment of Company Execs Online. During his interview, Docherty described the company’s DehydraTECH technology, which combines bioactive molecules like THC or CBD with fatty acids that reduce the flavour of cannabis and are better absorbed by the intestinal wall. He also outlined the company’s exposure to multiple markets in North America and beyond.
“Technology is really the heart of the company and it allows us to be active on a global scale,” said Docherty. “It allows us to apply this technology to companies in the United States, Canada we’ve even recently received patent protection in Australia so we offer our stakeholders a means to be participating in the functional food market place for cannabinoids or other bio actives, not only domestically but also on a global scale.”
To watch the full segment, click here.
Click here to connect with Lexaria Bioscience (CSE:LXX,OTCQB:LXRP) for an Investor Presentation
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/